

Author: Aminimanizani A.
Publisher: Adis International
ISSN: 0312-5963
Source: Clinical Pharmacokinetics, Vol.40, Iss.3, 2001-01, pp. : 169-187
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Comparative Tolerability of the Newer Fluoroquinolone Antibacterials
By Ball P.
Drug Safety, Vol. 21, Iss. 5, 1999-11 ,pp. :








By Cazzola M. Matera M.G. Donner C.F.
Clinical Drug Investigation, Vol. 16, Iss. 4, 1998-10 ,pp. :